← Back to catalogue

AlloSeq Tx

EUDAMED

Class C (EU MDR)

Ref 404.172-24Model AlloSeq Tx 17Ref 404.091-96Ref 404.171-24Ref 404.172-96Ref 404.112-96

by CareDx AB

Identity

Device Name
AlloSeq Tx EUDAMED
Model / Reference
AlloSeq Tx 17 EUDAMED
404.172-24 EUDAMED
404.091-96 EUDAMED
404.171-24 EUDAMED
404.172-96 EUDAMED
404.112-96 EUDAMED

Identifiers

Primary DI / UDI-DI
07340035526018 EUDAMED
07340035526049 EUDAMED
07340035526001 EUDAMED
07340035526032 EUDAMED
07340035526148 EUDAMED
Basic UDI-DI
73400355ASTXLU EUDAMED
Direct Marketing DI
07340035526018 EUDAMED
07340035526049 EUDAMED
07340035526032 EUDAMED
07340035526148 EUDAMED
EMDN Code
W01030403 HLA ANTIGEN TYPING EUDAMED

Classification

Device Class
Class C EUDAMED
Market of Registration
Sweden EUDAMED

Clinical & Handling

Sterile

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Microbial Substances

Yes

EUDAMED

Reagent

Yes

EUDAMED

Self Testing

No

EUDAMED

Near-Patient Testing

No

EUDAMED

Professional Testing

Yes

EUDAMED

Companion Diagnostics

No

EUDAMED

Surgical Instrument

No

EUDAMED

New Device

No

EUDAMED

Category: HLA class I & II antigen tissue typing IVD, kit, multiplex

AlloSeq Tx by CareDx AB — Class C — IVDR — listed in EUDAMED — regulatory data on deviCERTS

Similar devices

Also classified as HLA class I & II antigen tissue typing IVD, kit, multiplex.

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/IVDR

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
CareDx AB
EUDAMED SRN
SE-MF-000040995

Sources (5)

  • EUDAMED 523d0dd9-e743-4e0a-a80d-bea13f1ba22b 61 fields · synced Jul 24, 2026
  • EUDAMED 0ee63cde-6c2b-4ccd-9976-318ddeed7eac 61 fields · synced May 17, 2026
  • EUDAMED bcea3fdb-dcca-417b-95db-dae388c9397a 61 fields · synced May 18, 2026
  • EUDAMED ee297b28-834b-4c48-bdcc-407e33e99817 61 fields · synced May 19, 2026
  • EUDAMED 51229d0c-6197-4b65-bb63-c0f29910bf01 61 fields · synced Jul 10, 2026